A review of atomoxetine effects in young people with developmental disabilities.

•Ten published trials and one case study of atomoxetine in developmental disabilities.•Only two controlled clinical trials; and only one non-acute extension.•Individuals with intellectual disability especially neglected in studies.•Improved attention, impulsivity, overactivity, oppositional behavior often reported.•Common adverse events include anorexia, nausea, and irritability/mood.